American College of Rheumatology

ACR Journals On Air

Health EN ↓ 107 episodes

Welcome to "ACR Journals on Air," the ACR's newest podcast series featuring interviews, commentary, and analysis on research from our three peer-reviewed journals. Join us each episode for engaging discussions with authors and independent experts about recently published studies, their implications for clinical care, and how they move the field of rheumatology forward. Whether it's an expert analysis of a manuscript or deep dive with an author – our goal is the same – to understand the impact of the science and bring it from the bench to the bedside

Be sure to visit the podcast's website and support the creator: www.rheumatology.org

Author

American College of Rheumatology

Category

Health

Podcast website

www.rheumatology.org

Latest episode

Nov 10, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Medication-induced rheumatic syndromes 10.11.2026

In this episode, Dr. Ambreesh Chawla offers a preview of his upcoming ACR Convergence session exploring the complex relationship between medications and rheumatologic disease. He discusses unusual rheumatologic complications associated with commonly prescribed medications, including dupilumab-associated enthesitis, proton pump inhibitors (PPIs), and DPP-4 inhibitors. Through interactive cases and...

Assessing Reliability of an Electronic Gout Flare Assessment Protocol 27.10.2026

In this episode, Dr. Shravani Chitineni and Dr. Misti Paudel discuss their pilot study embedded within the TRUST (Treat-to-Avoid Symptoms in Gout) Trial, exploring how different methods of assessing gout flares compare. They share their findings on electronic versus telephone-based flare assessments, the challenges and opportunities of conducting research within an ongoing randomized controlled tr...

Autoimmune Disease Risk with GLP-1RA, DPP-4i and SGLT2i Treatment in Patients with Diabetes 13.10.2026

In this episode, we explore research investigating the potential association between newer anti-diabetic medications and autoimmune diseases in patients with diabetes.  Dr. Sparks and Arjun Mahajan discuss their innovative study using the TriNetX Global Collaborative Network, explaining their methods, key findings, clinical implications, and study limitations. They also share insights into the men...

The Gut-Heart Axis in Systemic Sclerosis 29.09.2026

What does the gut have to do with the heart in scleroderma? Quite a lot, as it turns out. In this episode, we talk with Dr. Zsuzsanna McMahan about new findings from the GENISOS cohort exploring the relationship between gastrointestinal and cardiac manifestations in systemic sclerosis, including the striking timing and strength of these associations and what they might reveal about shared disease...

Measuring the Impact: MRI Response of SI Joints in Youth with Axial SpA 15.09.2026

In this episode, we speak with Dr. Pamela Weiss, pediatric rheumatologist, epidemiologist, and physician-scientist at Children's Hospital of Philadelphia, about axial juvenile spondyloarthritis ( axJSpA ). Dr. Weiss discusses her study examining MRI findings in children and young adults receiving TNF inhibitors, including changes in sacroiliac joint inflammation, the relationship between imaging a...

Risk Factors for Relapse in ANCA Vasculitis 01.09.2026

In this episode, we speak with Dr. Ellen Romich about her post hoc analysis of the RITAZAREM trial, exploring factors associated with relapse in ANCA-associated vasculitis. She discusses the study design, key findings—including the roles of rituximab, azathioprine, CD19 positivity, ANCA status, and immune reconstitution—and the clinical implications and limitations of the work. Dr. Romich also sha...

Significance of a Positive ANA in Patients Without Autoimmune Diseases 18.08.2026

Dr. Vivian Kawai and Matthew Chung discuss their research on the clinical significance of high-titer antinuclear antibodies (ANA) using electronic medical record data and PheWAS analysis. They explore the study's design, key findings, clinical implications, and limitations, while also discussing how an undergraduate research experience evolved into a successful mentorship and publication.   Clinic...

RA Inference in EHR 04.08.2026

In this episode, we explore how artificial intelligence and machine learning are advancing the use of electronic health record data in rheumatology. Dr. Kat discusses the development and validation of a natural language processing–based model to infer rheumatoid arthritis disease activity from structured and unstructured clinical data, its application in studying cardiovascular outcomes, and the c...

Distilling Still Disease: Interstitial Lung Disease and Still 21.07.2026

In this episode, Michael J. Ombrello, MD, explores how our understanding of Still's disease has evolved, from recognizing interstitial lung disease as a key manifestation to uncovering the immunologic and genetic factors that may shape disease severity. He discusses insights from a National Institutes of Health natural history study, including interferon signatures, HLA associations, drug-associat...

GLP-1 receptor agonists in the RISE registry 07.07.2026

In this episode, Nicholas P. McCormic discusses new real-world research from the RISE registry examining the use of GLP-1 receptor agonists in patients with rheumatic and musculoskeletal diseases. He explains the motivation behind the study, its design, and key findings on medication use, weight loss, and differences between semaglutide and tirzepatide, while highlighting important considerations...

VAT: A Visualization and Analysis Tool for Scleroderma 23.06.2026

In this episode, we talk with Dr. Ji Soo Kim about a new tool designed to help people with scleroderma better understand and manage their disease. Using information collected over many years from patients receiving routine care, Dr. Kim developed an interactive platform that turns complex medical data into easy-to-understand charts and predictions. We discuss how the tool can help patients and doc...

Late-Onset Scleroderma Renal Crisis 09.06.2026

In this episode, we speak with Dr. Swati Mehta and Dr. Lee Schulman Shapiro about their study examining early- and late-onset scleroderma renal crisis using data from three patient cohorts. They discuss key clinical findings, including  important differences  related to sex, autoantibodies, presentation, dialysis outcomes, and long-term prognosis, as well as the implications for patient care. The...

AI for Nonpharmacologic Management of Chronic Rheumatic Diseases 26.05.2026

In this episode, we speak with Dr. Nirali Shah about the growing role of artificial intelligence in healthcare and rehabilitation. Drawing from her recent scoping review, Dr. Shah discusses the evidence behind AI-driven health apps for education, exercise, gait retraining, clinical decision support, remote patient monitoring, and pain management. The conversation also explores the challenges, risk...

Multibiomarker Panel for RA-ILD 12.05.2026

In this episode, we explore the emerging role of biomarkers in rheumatoid arthritis–associated interstitial lung disease (RA-ILD) with Dr. Brent Luedders, discussing how prior ILD research laid the foundation for his latest multi-cohort study. He walks us through the study design, including the use of VA and non-VA cohorts, the biomarker panel that was tested, and the key findings related to preva...

Apremilast in Immune Checkpoint Inhibitor Psoriasis and Psoriatic Arthritis 28.04.2026

In this episode, Drs. Nilasha Ghosh and Anne Bass discuss immune-related adverse events from immune checkpoint inhibitors, focusing on psoriasis and psoriatic arthritis. They review early clinical recognition, epidemiology, and findings from a multicenter observational study evaluating apremilast, including patient characteristics, outcomes, and key limitations. The conversation also highlights in...

Genetic Risk Score for Pain in RA 14.04.2026

In this episode, Dr. Katie McMenamin and Dr. Josh Baker discuss their research on the genetic drivers of pain in rheumatoid arthritis,  drawing on  data from the FORWARD and VARA cohorts. They explore how genetic risk scores relate to pain and disease activity, and what these findings mean for patient care, remission, and future clinical trials. The conversation also highlights key study limitatio...

Peripheral Blood Gene Expression and Scleroderma Lung Disease 31.03.2026

In this episode,  Dr.  Shervin Assassi discusses a secondary analysis of the SENSCIS trial, exploring how peripheral blood gene expression may predict response to mycophenolate in systemic sclerosis–associated lung disease. He highlights key findings linking immune and metabolic gene signatures, as well as C-reactive protein, to changes in lung function, and considers their potential role in guidi...

SARD Risk and Environmental Exposures 17.03.2026

In this episode, we speak with Dr. Sasha Bernatsky about her research on the relationship between exposure to fine particulate air pollution and the development of systemic autoimmune rheumatic diseases. She explains what fine particulate matter is, how her team used large population datasets to study environmental exposures, and what their findings suggest about the potential health impacts of ai...

Fecal Metabolome in Early Systemic Sclerosis 03.03.2026

In this episode, Dr. Elizabeth Volkmann discusses emerging research on the gut microbiome in systemic sclerosis, building on findings from early-diagnosis and prior microbiome studies. She explains her team's analysis of microbiome-derived metabolites, including short-chain fatty acids, and their potential role in symptom development, highlighting key findings, clinical implications, and study lim...

Mortality in RA Patients Treated with Immune Checkpoint Inhibitors (ICIs) 17.02.2026

In this episode, Dr. Madeline O'Sullivan discusses her retrospective study of U.S. veterans in the Veterans Health Administration, examining outcomes among patients with rheumatoid arthritis treated with immune checkpoint inhibitors for cancer. She explains how the cohorts were defined, how use and timing of immunosuppressive therapies were analyzed, and how mortality and cause of death were  dete...

JDM Treat to Target 03.02.2026

In this episode, we speak with Dr. Jayne MacMahon about an international collaborative study in juvenile dermatomyositis (JDM) involving pediatric rheumatology centers in Genoa, Italy, and Toronto, Canada. She discusses the study's motivation, key disease activity measures, treatment targets, and definitions of remission, along with major findings on time to remission, steroid exposure, and treatm...

TNF Inhibitors and Risk of Serious Infection in Pregnancy 20.01.2026

In this episode, we sit down with Dr. Evelyne Vinet about a new study examining whether TNF inhibitors increase the risk of serious infections during pregnancy among women with chronic inflammatory diseases. Using large real-world data from the  M arketScan   database, the discussion explores how pregnancy, inflammatory disease, TNF inhibitor exposure, and serious infections were defined, how conf...

What Are the Predictors For Difficult to Treat RA? 06.01.2026

In this episode, we explore why rheumatoid arthritis matters to the broader public, with a focus on difficult-to-treat RA (D2T-RA)—what it is, how often it occurs, and why early identification is critical. Our guest demystifies common RA research terms and outcome measures, introduces the real-world data sets behind the study, and explains—in plain language—how a predictive model was developed usi...

Can Ultrasound Detect Aneurysms in Giant Cell Arteritis? 09.12.2025

In this episode, we speak with a leading investigator in large-vessel vasculitis , Dr. Anne Bull Haaversen,  to clarify the full spectrum of giant cell arteritis (GCA), including its aortic involvement. We reviewed the prevalence of GCA-related aneurysms, why the team compared ultrasonography with other imaging modalities, and how the ascending aorta can be assessed with ultrasound. Our Dr. Haaver...

Can Age-related Assumptions Obstruct Rheumatic Care? 25.11.2025

In this episode, we sit down with Dr. Aaron Smith to explore why the rheumatology community urgently needs stronger grounding in aging principles and more adaptable care strategies for older adults living with rheumatic conditions. Dr. Smith walks us through his innovative research examining the attitudes and perspectives of healthcare professionals, explains how tools like the ERA-12 help illumin...

Listen to the ACR Journals On Air podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.